A selective histone deacetylase inhibitor for myeloma

被引：0
|
作者：
Pratt, Guy [1 ]
机构：
[1] Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2WB, W Midlands, England
来源：
LANCET ONCOLOGY | 2016年 / 17卷 / 11期
关键词：
PANOBINOSTAT PLUS BORTEZOMIB; MULTIPLE-MYELOMA; DEXAMETHASONE;
D O I：
10.1016/S1470-2045(16)30407-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1472 / 1474
页数：4
相关论文
共 50 条
  • [41] Design and synthesis of a potent histone deacetylase inhibitor
    Liu, Tao
    Kapustin, Galina
    Etzkorn, Felicia A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (09) : 2003 - 2006
  • [42] Histone Deacetylase Inhibitor for NUT Midline Carcinoma
    Maher, Ossama M.
    Christensen, Anthony M.
    Yedururi, Sireesha
    Bell, Diana
    Tarek, Nidale
    PEDIATRIC BLOOD & CANCER, 2015, 62 (04) : 715 - 717
  • [43] Romidepsin: a novel histone deacetylase inhibitor for cancer
    Bertino, Erin M.
    Otterson, Gregory A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (08) : 1151 - 1158
  • [44] The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma
    Kaiser, M
    Zavrski, L
    Sterz, J
    Jakob, C
    Fleissner, C
    Kloetzel, PM
    Sezer, O
    Heider, U
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02): : 248 - 251
  • [45] Pterostilbene: A Novel Histone Deacetylase 1 Inhibitor (HDACi1) Demonstrating Efficacy in Multiple Myeloma
    Chen, Haiming
    Hao, Rui
    Sanchez, Eric
    Shen, Jing
    Li, Mingjie
    Wang, Jessica
    Wong, Emily
    Adler, Anoushka
    Hu, Mengyin
    Leung, Crystal
    Wang, Cathy S.
    Li, Zhi-Wei
    Bonavida, Benjamin
    Berenson, James R.
    BLOOD, 2009, 114 (22) : 1478 - 1479
  • [46] RICOLINOSTAT (ACY-1215), THE FIRST SELECTIVE HISTONE DEACETYLASE 6 INHIBITOR, IS ACTIVE AND WELL TOLDERATED IN COMBINATION WITH LENALIDOMIDE OR BORTEZOMIB IN PATIENTS WITH REFRACTORY MYELOMA
    Raje, N.
    Vogl, D.
    Bensinger, W.
    Voorhees, P.
    Hari, P.
    Berdeja, J.
    Jagannath, S.
    Jones, S.
    Wheeler, C.
    Supko, J.
    Orlowski, R.
    Richardson, P.
    Lonial, S.
    HAEMATOLOGICA, 2014, 99 : 107 - 108
  • [47] Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors
    Hideshima, T.
    Mazitschek, R.
    Santo, L.
    Mimura, N.
    Gorgun, G.
    Richardson, P. G.
    Raje, N.
    Anderson, K. C.
    LEUKEMIA, 2014, 28 (02) : 457 - 460
  • [48] The Novel Subtype-Selective Histone Deacetylase (HDAC) Inhibitor, Chidamide, Exerts Dual Anti-Myeloma and Bone Protective Effect in Vitro and In Vivo
    He, Jingsong
    Chen, Qingxiao
    Yang, Yang
    Li, Yi
    Yang, Li
    Huang, He
    Yi, Qing
    Cai, Zhen
    BLOOD, 2017, 130
  • [49] Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors
    T Hideshima
    R Mazitschek
    L Santo
    N Mimura
    G Gorgun
    P G Richardson
    N Raje
    K C Anderson
    Leukemia, 2014, 28 : 457 - 460
  • [50] Synthesis and Evaluation of 9-epi-Koshidacin B as Selective Inhibitor of Histone Deacetylase 1
    Ghosh, Rajat
    Biswas, Sima
    Bagchi, Angshuman
    Chattopadhyay, Shital K.
    JOURNAL OF NATURAL PRODUCTS, 2024, 87 (12): : 2757 - 2767
12345